Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17219851 | 0.86 | — | — | |
| SCHEMBL7193102 | 0.82 | — | — | |
| SCHEMBL7780805 | 0.72 | — | — | |
| SCHEMBL4404945 | 0.70 | CYP2D6 (0.32) | CYP2D6CYP2C19 | |
| SCHEMBL565528 | 0.67 | — | — | |
| SCHEMBL8660707 | 0.62 | — | — | |
| SCHEMBL17385970 | 0.60 | CYP1A2 (0.38) | — | |
| SCHEMBL1698144 | 0.59 | CYP2D6 (0.49) | CYP2D6CYP2C19 | |
| SCHEMBL7638347 | 0.59 | HPSE (0.33) | — | |
| SCHEMBL1426540 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2585569-A1 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2013-05-01 | — | — | EP | claimed |
| WO-2011163337-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2011-12-29 | — | — | WO | claimed |
| CN-108003057-A | A kind of continuous cracking production method of 2- methylene -4- cyanobutyraldehydes | 庆阳凯威尔能源化工有限公司 | 2018-05-08 | — | — | CN | disclosed |
| US-7501539-B2 | Process for the preparation of alkylidenecyclopentanone derivatives | FIRMENICH SA (CH) | 2009-03-10 | — | — | US | disclosed |
| US-20050187299-A1 | Process for the preparation of alkylidenecyclopentanone derivatives | FIRMENICH S.A. (CH) | 2005-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187299-A1 | Process for the preparation of alkylidenecyclopentanone derivatives | CYP1B1, AKR1C3, CYP1A1 | CYP2D6 27/4885CYP2C19 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.